{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:11:07Z","timestamp":1790727067744,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer UK","award":["PRCNPG-Nov24\/100001"],"award-info":[{"award-number":["PRCNPG-Nov24\/100001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Activated platelets have been shown to promote tumorigenesis of several solid, largely gastrointestinal, tumours through the biosynthesis of cyclooxygenase-1-dependent thromboxane A2 (TXA2). The biosynthesis of the proinflammatory prostaglandin E2 (PGE2) has also been implicated in the progression of those solid tumours. Preclinical data suggest that platelet activation and PGE2 may contribute to melanoma progression, but clinical evidence is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate whether melanoma is associated with increased in vivo platelet activation and PGE2 biosynthesis, as assessed by urinary 11-dehydro-thromboxane B2 (11-dehydro-TXB2) and PGE2 metabolite (PGEM) levels, respectively, as compared with basal cell carcinoma (BCC) and healthy control samples; we also explored their potential relevance as biomarkers of melanoma progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We measured urinary 11-dehydro-TXB2, a major TXA2 metabolite and a biomarker of in vivo platelet activation, as well as PGEM, in patients with melanoma and in patients with BCC, using age- and sex-matched healthy participants as controls. Thirty patients with stage 1\u20133 melanoma [mean (SD) age 57 (15) years; 21 men] and 24 patients with BCC [mean (SD) age 60 (12) years; 11 men] voluntarily participated in the study; 38 age- and sex-matched healthy individuals [mean (SD) age 56 (17) years; 26 men] from previously published studies by our group were included as controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Urinary 11-dehydro-TXB2 was higher in patients with melanoma [median 1284 pg mg\u20131 creatinine; interquartile range (IQR) 892\u20131784] vs. those with BCC (median 583 pg mg\u20131 creatinine; IQR 393\u2013721) and healthy control participants (median 669 pg mg\u20131 creatinine; IQR 411\u20131184) (P &amp;lt; 0.001). Urinary 11-dehydro-TXB2 was comparable between patients with BCC and healthy control participants. We also studied six patients with stage 4 melanoma who showed the highest urinary 11-dehydro-TXB2 levels [1898.0 (IQR 1769.3\u20132622.1); P = 0.005 vs. all other groups]. PGEM levels did not differ among groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Melanoma, unlike BCC, is associated with increased biosynthesis of biomarkers of activated platelets. Urinary 11-dehydro-TXB2 may be tested as a prognostic biomarker for melanoma progression. Moreover, whether inhibition of platelet activation may be an adjuvant chemopreventive strategy warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/skinhd\/vzag120","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:45:21Z","timestamp":1782387921000},"page":"777-784","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced\n                    <i>in vivo<\/i>\n                    thromboxane biosynthesis in melanoma compared with basal cell carcinoma skin cancers"],"prefix":"10.1093","volume":"6","author":[{"given":"Giovanna","family":"Petrucci","sequence":"first","affiliation":[{"name":"Facolt\u00e0 Dipartimentale di Medicina e Chirurgia, Universit\u00e0 UniCamillus, Saint Camillus International University of Health Sciences , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Stefani","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, UOC Dermatologia, Fondazione Policlinico Universitario A. Gemelli \u2013 IRCCS , Rome ,","place":["Italy"]},{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Sezione Dermatologia, Universit\u00e0 Cattolica del Sacro Cuore , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rizzi","sequence":"additional","affiliation":[{"name":"UOSD Diabetologia, Universit\u00e0 Cattolica del Sacro Cuore , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Di Nardo","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Sezione Dermatologia, Universit\u00e0 Cattolica del Sacro Cuore , Rome ,","place":["Italy"]},{"name":"Immunology Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli \u2013 IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Del Regno","sequence":"additional","affiliation":[{"name":"UOSD Dermatologia, Ospedale \u2018Andrea Tortora\u2019, ASL Salerno , Pagani ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0604-9079","authenticated-orcid":false,"given":"Mohammad A","family":"Farhoud","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Sezione di Farmacologia, Universit\u00e0 Cattolica del Sacro Cuore , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, UOC Dermatologia, Fondazione Policlinico Universitario A. Gemelli \u2013 IRCCS , Rome ,","place":["Italy"]},{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Sezione Dermatologia, Universit\u00e0 Cattolica del Sacro Cuore , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-6423","authenticated-orcid":false,"given":"Bianca","family":"Rocca","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia, Libera Universit\u00e0 Mediterranea (LUM) , Casamassima (Bari) ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"2026092919520426700_vzag120-B1","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: diagnostics and prevention \u2013 update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026092919520426700_vzag120-B2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma \u2013 update 2023","volume":"192","author":"Peris","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026092919520426700_vzag120-B3"},{"key":"2026092919520426700_vzag120-B4","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics \u2013 update 2024","volume":"215","author":"Garbe","year":"2025","journal-title":"Eur J Cancer"},{"key":"2026092919520426700_vzag120-B5"},{"key":"2026092919520426700_vzag120-B6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/09537104.2018.1492105","article-title":"Aspirin, platelet inhibition and cancer prevention","volume":"29","author":"Patrignani","year":"2018","journal-title":"Platelets"},{"key":"2026092919520426700_vzag120-B7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01805","article-title":"Platelets, thrombo-\u00adinflammation, and cancer: collaborating with the enemy","volume":"10","author":"Palacios-Acedo","year":"2019","journal-title":"Front Immunol"},{"key":"2026092919520426700_vzag120-B8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01350","article-title":"Platelets and metastasis: new implications of an old interplay","volume":"10","author":"Lucotti","year":"2020","journal-title":"Front Oncol"},{"key":"2026092919520426700_vzag120-B9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1172\/JCI121985","article-title":"Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2","volume":"129","author":"Lucotti","year":"2019","journal-title":"J Clin Invest"},{"key":"2026092919520426700_vzag120-B10","doi-asserted-by":"crossref","first-page":"32462","DOI":"10.18632\/oncotarget.8655","article-title":"Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells","volume":"7","author":"Guillem-Llobat","year":"2016","journal-title":"Oncotarget"},{"key":"2026092919520426700_vzag120-B11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01244","article-title":"Measurement of thromboxane biosynthesis in health and disease","volume":"10","author":"Patrono","year":"2019","journal-title":"Front Pharmacol"},{"key":"2026092919520426700_vzag120-B12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jacc.2022.04.034","article-title":"Association of thromboxane generation with survival in aspirin users and nonusers","volume":"80","author":"Rade","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026092919520426700_vzag120-B13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41416-023-02310-1","article-title":"Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial","volume":"129","author":"Joharatnam-Hogan","year":"2023","journal-title":"Br J Cancer"},{"key":"2026092919520426700_vzag120-B14","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(20)30366-4","article-title":"Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial","volume":"395","author":"Burn","year":"2020","journal-title":"Lancet"},{"key":"2026092919520426700_vzag120-B15","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106338","article-title":"Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer","volume":"144","author":"Karpisheh","year":"2019","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2026092919520426700_vzag120-B16","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/ijd.17711","article-title":"The role of prostaglandin pathway and EP receptors in skin cancer development","volume":"64","author":"St Denis","year":"2025","journal-title":"Int J Dermatol"},{"key":"2026092919520426700_vzag120-B17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"2026092919520426700_vzag120-B18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2337\/db15-0936","article-title":"In vivo platelet activation and aspirin responsiveness in type 1 diabetes","volume":"65","author":"Zaccardi","year":"2016","journal-title":"Diabetes"},{"key":"2026092919520426700_vzag120-B19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/10253890.2010.545458","article-title":"Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects","volume":"14","author":"Simeoni","year":"2011","journal-title":"Stress"},{"key":"2026092919520426700_vzag120-B20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032835","article-title":"Urinary prostaglandin E2 excretion and the risk of cardiovascular and kidney disease","volume":"13","author":"Geurts","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026092919520426700_vzag120-B21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/eurheartj\/ehad868","article-title":"Thromboxane biosynthesis and future events in diabetes: the ASCEND trial","volume":"45","author":"Petrucci","year":"2024","journal-title":"Eur Heart J"},{"key":"2026092919520426700_vzag120-B22","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/ac00284a003","article-title":"Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay","volume":"57","author":"Pradelles","year":"1985","journal-title":"Anal Chem"},{"key":"2026092919520426700_vzag120-B23"},{"key":"2026092919520426700_vzag120-B24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026092919520426700_vzag120-B25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"2026092919520426700_vzag120-B26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jtha.2024.12.016","article-title":"Platelets and megakaryocytes in cancer","volume":"23","author":"Josefsson","year":"2025","journal-title":"J Thromb Haemost"},{"key":"2026092919520426700_vzag120-B27","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.21873\/anticanres.17570","article-title":"Role of platelet interactions in promoting melanoma malignancy with insights into proliferation, cyclin D1 expression, and migration","volume":"45","author":"Yoshikawa","year":"2025","journal-title":"Anticancer Res"},{"key":"2026092919520426700_vzag120-B28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12964-024-01973-4","article-title":"Platelet-derived extracellular vesicles induced through different activation pathways drive melanoma progression by functional and transcriptional changes","volume":"22","author":"Tavukcuoglu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"2026092919520426700_vzag120-B29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13046-023-02856-1","article-title":"Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment","volume":"42","author":"Chen","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"2026092919520426700_vzag120-B30","doi-asserted-by":"crossref","first-page":"19303","DOI":"10.1038\/s41598-020-75774-3","article-title":"Genetic analyses in mouse fibroblast and melanoma cells demonstrate novel roles for PDGF-AB ligand and PDGF receptor alpha","volume":"10","author":"Kadrmas","year":"2020","journal-title":"Sci Rep"},{"key":"2026092919520426700_vzag120-B31","doi-asserted-by":"crossref","first-page":"66833","DOI":"10.18632\/oncotarget.18706","article-title":"Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1","volume":"8","author":"Ruffini","year":"2017","journal-title":"Oncotarget"},{"key":"2026092919520426700_vzag120-B32","article-title":"Involvement of platelet-derived VWF in metastatic growth of melanoma in the brain","volume":"3","author":"Robador","year":"2021","journal-title":"Neurooncol Adv"},{"key":"2026092919520426700_vzag120-B33","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.21873\/invivo.13936","article-title":"Inhibitory effect of clopidogrel, a P2Y(12) receptor antagonist, on hematogenic metastasis in B16-BL6 mouse melanoma cells","volume":"39","author":"Yoshikawa","year":"2025","journal-title":"In Vivo (Brooklyn)"},{"key":"2026092919520426700_vzag120-B34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/pcmr.13021","article-title":"Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL","volume":"35","author":"Chen","year":"2022","journal-title":"Pigment Cell Melanoma Res"},{"key":"2026092919520426700_vzag120-B35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/jso.27748","article-title":"Analysis of the expression of cytokines and chemokines, platelet\u2013leukocyte aggregates, sCD40L and sCD62P in cutaneous melanoma","volume":"130","author":"Santos","year":"2024","journal-title":"J Surg Oncol"},{"key":"2026092919520426700_vzag120-B36","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jnci\/djad231","article-title":"Long-term aspirin use and cancer risk: a 20-year cohort study","volume":"116","author":"Skriver","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"2026092919520426700_vzag120-B37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115159","article-title":"Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy \u2013 a multicenter study on 2419 patients from the prospective skin cancer registry ADOReg","volume":"214","author":"Kott","year":"2025","journal-title":"Eur J Cancer"},{"key":"2026092919520426700_vzag120-B38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20892\/j.issn.2095-3941.2019.0339","article-title":"COX-2 as a potential biomarker and therapeutic target in melanoma","volume":"17","author":"Tudor","year":"2020","journal-title":"Cancer Biol Med"},{"key":"2026092919520426700_vzag120-B39","first-page":"203","article-title":"Differences of metabolism of prostaglandin E2 and F2 alpha by decidual stromal cells and macrophages in culture","volume":"4","author":"Ishihara","year":"1991","journal-title":"Eicosanoids"},{"key":"2026092919520426700_vzag120-B40","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/1055-9965.EPI-19-0597","article-title":"Urinary PGE-M levels and risk of ovarian cancer","volume":"28","author":"Barnard","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026092919520426700_vzag120-B41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/1940-6207.CAPR-20-0216","article-title":"Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: a randomized clinical trial","volume":"13","author":"Drew","year":"2020","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/5\/777\/70148361\/vzag120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/5\/777\/70148361\/vzag120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:52:15Z","timestamp":1790725935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/5\/777\/8742183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,7,27]]},"published-print":{"date-parts":[[2026,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzag120","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,27]]}}}